Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
This study is ongoing, but not recruiting participants.
Study NCT00003558   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma of Unknown Primary
Additional conditions recognized in this trial
Carcinoma
Neoplasms, Unknown Primary
More general conditions related to this trial
Neoplasm Metastasis
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
carboplatin
etoposide
fluorouracil
leucovorin calcium
paclitaxel
Additional drug interventions recognized in this trial
Etoposide phosphate
Leucovorin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Academisch Ziekenhuis Maastricht


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services